1. Home
  2. NEON vs FATE Comparison

NEON vs FATE Comparison

Compare NEON & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEON
  • FATE
  • Stock Information
  • Founded
  • NEON 1997
  • FATE 2007
  • Country
  • NEON Sweden
  • FATE United States
  • Employees
  • NEON N/A
  • FATE N/A
  • Industry
  • NEON Industrial Machinery/Components
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NEON Technology
  • FATE Health Care
  • Exchange
  • NEON Nasdaq
  • FATE Nasdaq
  • Market Cap
  • NEON 127.6M
  • FATE 108.2M
  • IPO Year
  • NEON 2007
  • FATE 2013
  • Fundamental
  • Price
  • NEON $9.06
  • FATE $1.11
  • Analyst Decision
  • NEON Strong Buy
  • FATE Hold
  • Analyst Count
  • NEON 1
  • FATE 8
  • Target Price
  • NEON $16.50
  • FATE $5.43
  • AVG Volume (30 Days)
  • NEON 92.9K
  • FATE 2.1M
  • Earning Date
  • NEON 05-07-2025
  • FATE 05-08-2025
  • Dividend Yield
  • NEON N/A
  • FATE N/A
  • EPS Growth
  • NEON N/A
  • FATE N/A
  • EPS
  • NEON N/A
  • FATE N/A
  • Revenue
  • NEON $3,108,000.00
  • FATE $13,631,000.00
  • Revenue This Year
  • NEON N/A
  • FATE N/A
  • Revenue Next Year
  • NEON $28.47
  • FATE N/A
  • P/E Ratio
  • NEON N/A
  • FATE N/A
  • Revenue Growth
  • NEON N/A
  • FATE N/A
  • 52 Week Low
  • NEON $1.37
  • FATE $0.66
  • 52 Week High
  • NEON $15.00
  • FATE $5.92
  • Technical
  • Relative Strength Index (RSI)
  • NEON 60.08
  • FATE 57.67
  • Support Level
  • NEON $7.00
  • FATE $0.87
  • Resistance Level
  • NEON $8.15
  • FATE $1.18
  • Average True Range (ATR)
  • NEON 0.66
  • FATE 0.14
  • MACD
  • NEON 0.11
  • FATE 0.04
  • Stochastic Oscillator
  • NEON 96.17
  • FATE 86.54

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in United States, Japan, South Korea, Germany, Switzerland, China, France, Sweden and Others. It derives maximum revenue from United States.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: